Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
Adverse drug events in Chinese pediatric inpatients and associated risk factors: a retrospective review using the
Huan-Huan Ji1, Lin Song1, Jian-Wen Xiao2
1Department of Pharmacy, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child development and Critical Disorders, Chongqing Key Laboratory of Pediatric, Children's Hospital of Chongqing Medical University, CHONGQING, 400014, China.
Insights
This study highlights that 12.7% of pediatric inpatients experienced adverse drug events (ADEs). A pediatric-focused Global Trigger Tool (GTT) effectively identified these events, aiding in harm reduction strategies.
Area of Science:
- Pediatric pharmacology
- Patient safety research
- Health informatics
Background:
- Adverse drug events (ADEs) pose significant risks to hospitalized children.
- Effective methods are needed to identify and prevent ADEs in pediatric populations.
- The Global Trigger Tool (GTT) is a validated method for retrospective harm assessment.
Purpose of the Study:
- To evaluate the epidemiology and risk factors of ADEs in pediatric inpatients.
- To assess the feasibility and utility of a pediatric-specific Global Trigger Tool (GTT) for ADE detection.
- To identify patient characteristics associated with increased risk of ADEs.
Main Methods:
- A three-stage retrospective chart review of 1800 pediatric inpatients (January 2013-December 2015).
- Development and application of 31 pediatric-specific triggers based on existing literature.
- Calculation of trigger positive predictive values (PPVs) and ADE detection rates.
- Stepwise logistic regression analysis to identify risk factors for ADEs.
Main Results:
- Out of 1746 analyzed patients, 221 (12.7%) experienced 247 ADEs.
- The overall PPV of the pediatric-focused trigger tool was 13.3%.
- The majority of ADEs were classified under categories E (82.6%), F (11.7%), and H (5.7%).
- Increased drug counts, doses, and prior admissions were associated with higher ADE risk.
Conclusions:
- The pediatric-focused GTT is a feasible and effective tool for detecting ADEs in hospitalized children.
- Identifying patients with multiple medications, high doses, or frequent admissions is crucial for targeted ADE prevention.
- This tool supports efforts to reduce harm from ADEs in pediatric care settings.
Abstract:
Understanding the epidemiology and risk factors of adverse drug events (ADEs) in pediatric inpatient is essential if we are to prevent, reduce or ameliorate the harm experienced. The Global Trigger Tool (GTT) is a method of retrospective medical record review that measures harm in hospitalized children. We employed a three-stage retrospective chart review of random samples of 1800 pediatric inpatients discharged from January 2013 to December 2015. 31 kinds of pediatric-specific triggers were made based on the previous trigger tool studies developed for use in adult or pediatric. Positive predictive value (PPV) of individual triggers, as well as ADEs detection rates were calculated. Stepwise logistic regression was performed to investigate risk factors associated with ADEs. Of 1746 patients, detected in 221 patients (12.7%) with 247 ADEs. The PPV of the trigger tool was 13.3%. Of the 247 ADEs, 82.6% were identified as category E, 11.7% category F and 5.7% category H. The pediatric-focused trigger tool is a feasible and useful tool for detecting pediatric ADEs. Especially for patients who have had more drugs, more doses or more admissions which needs to be closely monitored as triggers to improve the safety.
More Related Videos
Related Concept Videos
Drug Toxicity: Risk factors
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Global Climate Change
Pharmacokinetics in Pediatric Patients: Drug Distribution

